$MIST
Milestone Pharmaceuticals Inc. Common Shares
XNAS
Why is MIST down today? It is at $1.17 (-8.27%), and our scanner flagged it 22 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MIST spikes, and full due diligence on MIST — key stats, earnings, dilution and insider activity. Free.
Get free $MIST alerts the moment volume spikes
Our scanner flagged $MIST 22 times in the last 30 days. Create a free account to track $MIST, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $1.17
- Change today
- -8.27%
- Previous close
- $1.27
- 52-week range
- $1.00 – $3.06
- Market cap
- $158M
- Institutional own.
- 33.99%
- Total held
- 36.5%
- Tradeable float
- 79.1M 64% of shares · after 2% insiders + 34% institutions
- Short interest
- 15.7M ▲ +8% vs prior · as of 2026-07-31
- Short % of float
- 19.8%
- Days to cover
- 12.7d
- Avg daily volume
- 2.5M
- Exchange
- XNAS
- 5m
- 2.4x
- 15m
- 1.0x
- 1h
- 1.6x
- 1D
- 2.4x
Get free MIST + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $MIST down today?
MIST is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 10 unusual-volume and momentum alerts on MIST today, peaking at 65.8x its normal volume. Fresh from the SEC: Milestone Pharmaceuticals Inc.: Quarter 2026 Financial Results and Provides Corporate Update. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystQuarter 2026 Financial Results and Provides Corporate UpdateReported $170.6 million in cash, cash equivalents and short-termReported lives covered remained relatively unchanged through Q2 at approximately 25%; however, covered lives have significantly grown to approximatelyReported 50% to date as a result of recently reported formulary coverage for CARDAMYST from UnitedHealthcare and several other prominent commercial, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
0 buys, 0 sells last 3 months (5/14 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Oliveto Joseph Officer | Sold (automatic/other) | -37K 0.03% of company | sold 7.6% | 446K | $82K at $2.26 | Apr 16, 26 |
Muller Lorenz Officer | Sold (automatic/other) | -11K | sold 5.2% | 205K | $22K at $1.93 | Jan 26, 26 |
Muller Lorenz Officer | Other | 20K 0.02% of company | added 10% | 217K | n/a | Jan 26, 26 |
Oliveto Joseph Officer | Sold (automatic/other) | -35K 0.03% of company | sold 6.7% | 483K | $67K at $1.93 | Jan 26, 26 |
Oliveto Joseph Officer | Other | 67K 0.05% of company | added 15% | 517K | n/a | Jan 26, 26 |
Bharucha David Officer | Sold (automatic/other) | -12K | sold 9.8% | 113K | $24K at $1.93 | Jan 26, 26 |
Bharucha David Officer | Other | 20K 0.02% of company | added 19% | 125K | n/a | Jan 26, 26 |
Nelson Jeffrey Edward Officer | Sold (automatic/other) | -12K | sold 20% | 50K | $24K at $1.93 | Jan 26, 26 |
Nelson Jeffrey Edward Officer | Other | 20K 0.02% of company | added 48% | 62K | n/a | Jan 26, 26 |
Hasija Amit Officer | Sold (automatic/other) | -12K | sold 11% | 100K | $24K at $1.93 | Jan 26, 26 |
Hasija Amit Officer | Other | 20K 0.02% of company | added 22% | 112K | n/a | Jan 26, 26 |
Oliveto Joseph Officer | Sold (automatic/other) | -43K 0.03% of company | sold 12% | 304K | $97K at $2.25 | Jan 8, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfActive shelf on file — the company can issue new shares on demand (valid ~3 years). If $MIST runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$MIST Sentiment
NeutralBlend of news sentiment, today’s move, and community votes. Not investment advice.
$MIST Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
MIST stock FAQ
Why is $MIST down today?
MIST is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 10 unusual-volume and momentum alerts on MIST today, peaking at 65.8x its normal volume. Fresh from the SEC: Milestone Pharmaceuticals Inc.: Quarter 2026 Financial Results and Provides Corporate Update. A material company disclosure like this is often the real catalyst behind a move of this size.
What is the MIST stock price today?
MIST last traded at $1.17, down 8.27% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live MIST alerts?
The MIST Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MIST 22 times in the last 30 days.
What exchange is MIST on?
MIST (Milestone Pharmaceuticals Inc. Common Shares) trades on XNAS, with a market cap of about $158M.
Is MIST good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MIST for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.